Quick Answer
Tenon Medical, Inc. reported Total Revenue of $3.94 million for fiscal year 2025.
Tenon Medical, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $3.94M +20.4% |
$3.28M +11.9% |
$2.93M +323.7% |
$691.0K +331.9% |
$160.0K | — |
| Net Income | -$12.56M +8.2% |
-$13.67M +12.2% |
-$15.58M +17.6% |
-$18.92M -168.4% |
-$7.05M | — |
| Diluted EPS | -$1.70 +84.9% |
-$11.26 +83.6% |
-$68.64 -190.6% |
-$23.62 -202.4% |
-$7.81 | — |
| Total Assets | $10.76M +9.3% |
$9.84M +55.1% |
$6.34M -42.8% |
$11.09M +19.6% |
$9.27M | — |
| Cash and Equivalents | $3.76M -42.5% |
$6.54M +169.2% |
$2.43M +14.0% |
$2.13M -27.0% |
$2.92M | — |
| Stockholders Equity | $5.04M -15.6% |
$5.97M +667.5% |
$778.0K -87.6% |
$6.25M +130.4% |
-$20.55M -658.7% |
-$2.71M |
| R&D Expense | $2.15M -17.4% |
$2.60M -17.7% |
$3.16M +11.8% |
$2.83M +64.6% |
$1.72M | — |
| Operating Income | -$12.79M +7.1% |
-$13.77M +12.5% |
-$15.73M +16.0% |
-$18.73M -189.8% |
-$6.46M | — |
| Gross Profit | $2.36M +37.8% |
$1.71M +37.9% |
$1.24M +293.6% |
-$641.0K -710.5% |
$105.0K | — |
| Shares Outstanding | 10.85M +245.7% |
3.14M +865.7% |
325,039 -71.1% |
1.12M +13.5% |
989,954 | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.17M | +32.2% | +108.0% |
| Net Income | September 30, 2025 | -$3.34M | -4.9% | -20.6% |
| Diluted EPS | September 30, 2025 | -$0.40 | +89.0% | -11.1% |
| Total Assets | September 30, 2025 | $10.37M | -20.5% | -6.7% |
| Cash and Equivalents | September 30, 2025 | $3.44M | -62.4% | -56.1% |
| Stockholders Equity | September 30, 2025 | $4.80M | -41.4% | -28.5% |
| R&D Expense | September 30, 2025 | $428.0K | -34.9% | -14.9% |
| Operating Income | September 30, 2025 | -$3.39M | -5.5% | -18.7% |
| Gross Profit | September 30, 2025 | $773.0K | +84.9% | +215.5% |
| Shares Outstanding | September 30, 2025 | 8.61M | +174.4% | +13.3% |
- Tenon Medical, Inc. reported Total Revenue of $3.94 million for fiscal year 2025.
- Tenon Medical, Inc. showed an increase of +20.4% in Total Revenue compared to the prior fiscal year.
- Tenon Medical, Inc. reported Net Income of -$12.56 million for fiscal year 2025.
- Tenon Medical, Inc. showed an increase of +8.2% in Net Income compared to the prior fiscal year.
- Tenon Medical, Inc. reported Diluted EPS of $1.70 per share (loss) for fiscal year 2025.
- Tenon Medical, Inc. showed an increase of +84.9% in Diluted EPS compared to the prior fiscal year.
- Tenon Medical, Inc. reported Total Assets of $10.76 million for fiscal year 2025.
- Tenon Medical, Inc. showed an increase of +9.3% in Total Assets compared to the prior fiscal year.
- Tenon Medical, Inc. reported Cash and Equivalents of $3.76 million for fiscal year 2025.
- Tenon Medical, Inc. showed a decrease of -42.5% in Cash and Equivalents compared to the prior fiscal year.
- Tenon Medical, Inc. reported Stockholders Equity of $5.04 million for fiscal year 2025.
- Tenon Medical, Inc. showed a decrease of -15.6% in Stockholders Equity compared to the prior fiscal year.
- Tenon Medical, Inc. reported R&D Expense of $2.15 million for fiscal year 2025.
- Tenon Medical, Inc. showed a decrease of -17.4% in R&D Expense compared to the prior fiscal year.
- Tenon Medical, Inc. reported Operating Income of -$12.79 million for fiscal year 2025.
- Tenon Medical, Inc. showed an increase of +7.1% in Operating Income compared to the prior fiscal year.
- Tenon Medical, Inc. reported Gross Profit of $2.36 million for fiscal year 2025.
- Tenon Medical, Inc. showed an increase of +37.8% in Gross Profit compared to the prior fiscal year.
- Tenon Medical, Inc. reported Shares Outstanding of 10.85 million shares for fiscal year 2025.
- Tenon Medical, Inc. showed an increase of +245.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: